{"ticker": {"uuid": "a955950c-56d3-45f7-b803-cb42c2775d6e", "symbol": "GH", "name": "Guardant Health Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "How Expanded Coverage for Guardant\u2019s Shield Test Will Impact UnitedHealth Group (UNH) Investors", "summary": "UnitedHealth Group's decision to cover Guardant Health's Shield blood test for colorectal cancer screening for roughly 40 million members over 45 aligns with its focus on preventive care. While this move supports UnitedHealth's long-term investment narrative through innovation an", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-expanded-coverage-for-guardants-shield-test-will-impact/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T05:11:51", "published_display": "15 Jul 2026 05:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GH Maintained by Canaccord Genuity -- Price Target Raised to $20", "summary": "Canaccord Genuity has maintained a \"Buy\" rating for Guardant Health (GH) and raised its price target from $135 to $205, reflecting strong confidence in the company's future performance. Despite this positive analyst outlook and significant growth potential, Guardant Health's stoc", "url": "https://www.gurufocus.com/news/8957532/gh-maintained-by-canaccord-genuity-price-target-raised-to-205", "source_name": "GuruFocus", "published_at": "2026-07-14T14:16:23", "published_display": "14 Jul 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Expands Shield Test Access in India, But What Does It Reveal About Its Growth Strategy?", "summary": "Guardant Health (GH) is expanding access to its Shield Multi-Cancer Detection blood test in India through an agreement with Zydus Lifesciences and Apollo Hospitals. This move into a large healthcare market aims to broaden non-invasive cancer screening access and is part of Guarda", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-expands-shield-test-access-in-india-but-w/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-14T11:11:16", "published_display": "14 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Receives a Buy from Bank of America Securities", "summary": "Bank of America Securities reiterated a Buy rating for Guardant Health (GH) with a price target of $190.00. This recommendation comes despite a negative corporate insider sentiment, with more insiders selling shares recently. Guardant Health reported a quarterly revenue of $301.6", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3268965/guardant-health-gh-receives-a-buy-from-bank-of-america-securities/", "source_name": "The Globe and Mail", "published_at": "2026-07-14T10:11:16", "published_display": "14 Jul 2026 10:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scrap metal to hydrogen: GH Power\u2019s tech heads for NYSE via Matinas deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQWEZwZVplTHo4SE05TkVYQ0NWLTZEV2dBSkZyYlBwanFJZ1B0dnZZaDY2OEF6Mi1zRFZEakdfTWZDYkpZbHE5R1N0VzJtNVF4ZUJ5WGNFWGFKd0RNTkxuRDNxM3lKeEF3OGZTVXVONDZSMDFOcEVWeTJJWkQ0Q0pEXzVudDFaMWRVdGlzazNKNUxEbWd1eGR0S0lsSjE4QU9GbGJzMl9qTXIteUFHTFVMekJ5dldRZEhMR056ZXItaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T19:45:00+00:00", "published_display": "13 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Expanded Coverage of Guardant\u2019s Shield Test Reshape UnitedHealth Group\u2019s (UNH) Preventive Care Narrative?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/expanded-coverage-guardant-shield-test-100645520.html", "source_name": "Simply Wall St.", "published_at": "2026-07-13T10:06:45+00:00", "published_display": "13 Jul 2026 10:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Expands Shield In India On Valuation Views Staying Closely Split", "summary": "Guardant Health (GH) recently announced partnerships with Zydus Lifesciences and Apollo Hospitals to launch its Shield Multi Cancer Detection blood test in India. The stock has seen significant momentum, but valuation views are split, with some analysts considering it slightly ov", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-expands-shield-in-india-on-valuation-view", "source_name": "Simply Wall Street", "published_at": "2026-07-12T19:40:27", "published_display": "12 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $175", "summary": "Morgan Stanley has reiterated its \"Buy\" rating on Guardant Health (GH.US) and increased its price target to $175. This positive outlook suggests continued confidence from the financial institution in the company's growth prospects. The raised target price indicates a belief in po", "url": "https://www.moomoo.com/news/post/72713728/morgan-stanley-maintains-guardant-health-ghus-with-buy-rating-raises", "source_name": "Moomoo", "published_at": "2026-07-10T05:10:57", "published_display": "10 Jul 2026 05:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High", "summary": "", "url": "https://finance.yahoo.com/m/de3508cb-1479-32d9-aa1c-a2f6bccc4228/the-surprising-reason.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-09T20:23:19+00:00", "published_display": "09 Jul 2026 20:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/guardant-health-report-second-quarter-200500522.html", "source_name": "Business Wire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026", "summary": "Guardant Health (NASDAQ: GH) will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will also host a conference call and webcast to discuss the results and provide a business update at 4:30 PM ET / 1:30 PM PT on the same ", "url": "https://www.moomoo.com/news/post/72736063/press-release-guardant-health-to-report-second-quarter-2026-financial", "source_name": "Moomoo", "published_at": "2026-07-09T20:51:31", "published_display": "09 Jul 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock May Be Fully Priced As Shield Coverage Expands", "summary": "Guardant Health (GH) has seen a strong 3-year return of 313.6%. While a Discounted Cash Flow (DCF) model suggests the stock is undervalued by 16.1% at around $186 per share, market-based multiples, particularly the P/S ratio of 19.2x (compared to an industry average of 1.5x), ind", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-may-be-fully-priced-as-shield-cover", "source_name": "Simply Wall Street", "published_at": "2026-07-09T19:51:31", "published_display": "09 Jul 2026 19:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health sets July 30 call for Q2 2026 results", "summary": "Guardant Health (Nasdaq: GH) announced it will report its second-quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The webcast will ", "url": "https://www.stocktitan.net/news/GH/guardant-health-to-report-second-quarter-2026-financial-results-on-j1qbfbjdgjp8.html", "source_name": "Stock Titan", "published_at": "2026-07-09T17:11:16", "published_display": "09 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. Stock 12\u2011Month Price Target Raised to $161.13, Implies 3% Upside", "summary": "Guardant Health, Inc. (GH) has seen its average 12-month price target raised to $161.13 by 23 analysts, up from $159.17, implying a 3% potential upside from its July 8 closing price. The consensus rating for GH remains a \"Buy\" among 29 analysts, with 25 recommending Buy, 2 Hold, ", "url": "https://www.tradingview.com/news/tradingview:ffee8f602e118:0-guardant-health-inc-stock-12-month-price-target-raised-to-161-13-implies-3-upside/", "source_name": "TradingView", "published_at": "2026-07-09T13:41:18", "published_display": "09 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Slides as Investors Appear to Take Profits After Recent Rally", "summary": "This article analyzes Guardant Health's stock performance, noting a recent decline likely due to profit-taking after a rally. It will detail the company's financial health, analyst forecasts, and various metrics to provide context for investors. The report aims to offer a compreh", "url": "https://www.moomoo.com/news/post/72694841/guardant-health-slides-as-investors-appear-to-take-profits-after", "source_name": "Moomoo", "published_at": "2026-07-08T21:41:18", "published_display": "08 Jul 2026 21:41", "sentiment": "negative", "sentiment_pct": 32, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Guardant Health, Inc. Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold Guardant Health, Inc. stocks, providing key financial metrics for each. The data includes market value, weight, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year NAV total re", "url": "https://www.tradingview.com/symbols/MIL-1GH/etfs/", "source_name": "TradingView", "published_at": "2026-07-07T12:12:28", "published_display": "07 Jul 2026 12:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To UnitedHealth Group (UNH) Covering Guardant\u2019s Shield Blood Test For Colon Cancer", "summary": "UnitedHealth Group has announced coverage for Guardant Health's Shield blood test for colorectal cancer screening for eligible members, making it the first major commercial insurer to do so. While this move strengthens UnitedHealth's preventive care focus, the article suggests it", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-investors-may-respond-to-unitedhealth-group-unh-covering/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-07T07:12:28", "published_display": "07 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. Stock 12\u2011Month Price Target Raised to $156.35, Implies 7% Downside", "summary": "Analyst estimates for Guardant Health, Inc. (GH) show an average 12-month price target increase from $153.96 to $156.35, implying a potential 7% downside from the current closing price. Despite this, the consensus rating from 29 analysts remains \"Buy,\" with a majority recommendin", "url": "https://www.tradingview.com/news/tradingview:2c5a4dcdae377:0-guardant-health-inc-stock-12-month-price-target-raised-to-156-35-implies-7-downside/", "source_name": "TradingView", "published_at": "2026-07-06T16:40:40", "published_display": "06 Jul 2026 16:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock hits 52-week high at $172.67", "summary": "Guardant Health Inc. (GH) stock recently hit a 52-week high of $172.67, with a year-over-year total return of 232.63%. Despite its robust performance and 39.56% revenue growth, InvestingPro analysis suggests the stock is overvalued and potentially overbought. The company also rec", "url": "https://www.investing.com/news/company-news/guardant-health-stock-hits-52week-high-at-17267-93CH-4777030", "source_name": "Investing.com", "published_at": "2026-07-06T15:40:40", "published_display": "06 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA Securities Adjusts Price Target on Guardant Health to $190 From $135", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bofa-securities-adjusts-price-target-123817219.html", "source_name": "MT Newswires", "published_at": "2026-07-06T12:38:17+00:00", "published_display": "06 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health: Great Execution, But At An Excessive Premium (NASDAQ:GH)", "summary": "Guardant Health (GH) is seeing increased credibility for its Shield product, supported by Quest access and expanded coverage, alongside a strong oncology franchise. While the company's execution is strong and the stock has risen sharply, the author believes the current valuation ", "url": "https://seekingalpha.com/article/4920051-guardant-health-great-execution-but-at-an-excessive-premium?source=generic_rss", "source_name": "Seeking Alpha", "published_at": "2026-07-06T10:15:00", "published_display": "06 Jul 2026 10:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion", "summary": "Guardant Health (GH) recently saw a 12.6% stock increase following two significant developments: an exclusive deal with Zydus Lifesciences to bring its Shield Multi-Cancer Detection blood test to India, and expanded coverage for the Shield test through UnitedHealth. These agreeme", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-is-up-126-after-india-shield-cancer-test", "source_name": "Simply Wall Street", "published_at": "2026-07-06T03:10:37", "published_display": "06 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock surges on colon cancer blood test news", "summary": "Guardant Health's stock surged after UnitedHealth Group agreed to cover its Shield blood test for colon cancer as a first-line screening option for millions of members. This decision led Bernstein SocGen Group to raise its price target for Guardant Health to $200, highlighting a ", "url": "https://www.thestreet.com/investing/stocks/gh-guardant-health-stock-target-bernstein-colon-cancer-blood-test", "source_name": "TheStreet", "published_at": "2026-07-05T15:39:38", "published_display": "05 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CPO logs RSU vesting and $170.77 tax-withholding share transfer", "summary": "Guardant Health's Chief People Officer, Terilyn J. Monroe, reported the vesting of 4,020 restricted stock units (RSUs) on July 1, 2026. The company withheld 2,099 shares at $170.77 per share to cover tax obligations. Following these transactions, Ms. Monroe retains a significant ", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-c1f285b2c34d.html", "source_name": "Stock Titan", "published_at": "2026-07-03T13:40:29", "published_display": "03 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock May Look Fully Valued Following Shield Coverage News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTzNxVHdpMjQzWGtvSmhuODBUVlNOS0tvdG9PQl8wejFPM0txM0d5Z21rajEwUThrWkd1dzFoWGlKaVdBNC1ldGNQZlIyUVptUFljQnA1SUpRQy1hcW02cGw1T2YzcWtHdUJCX2dZVy1Nb2dfSFpLNTVwWHY5Z1lyWEg3eHRNZm5fLUZiVTZ1RDMxX2pFdVpveg?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CLO exercises RSUs as shares withheld for taxes", "summary": "Guardant Health's Chief Legal Officer, John G. Saia, had 7,063 restricted stock units (RSUs) vest, converting into common stock on July 1, 2026. The company withheld 3,707 shares, valued at $170.77 per share, to cover tax obligations related to this vesting event. This transactio", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-8c9f4050172b.html", "source_name": "Stock Titan", "published_at": "2026-07-03T02:09:26", "published_display": "03 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) director converts 155 RSUs into common shares", "summary": "Guardant Health director Steve E. Krognes converted 155 Restricted Stock Units (RSUs) into common shares on June 30, 2026. This transaction represents a compensation-related vesting event and not an open-market purchase or sale. After the conversion, Mr. Krognes directly holds 14", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-93e5ebf47f2e.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:12:25", "published_display": "02 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CCO receives 7,414 shares from RSU vesting and tax withholding", "summary": "Guardant Health's Chief Commercial Officer, Chris Freeman, received 7,414 shares through the vesting of restricted stock units (RSUs) on July 1, 2026. This transaction involved the conversion of RSU awards into common stock, with 3,141 shares withheld by the company to cover tax ", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-ee7cb37ac0fb.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:12:25", "published_display": "02 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock rating reiterated at Buy by TD Cowen on UnitedHealth coverage", "summary": "TD Cowen has reiterated a Buy rating and a $127.00 price target for Guardant Health (NASDAQ:GH) following UnitedHealth's decision to cover the Shield colorectal cancer screening test. This coverage, effective August 1, 2026, for average-risk individuals aged 45-85, is expected to", "url": "https://www.investing.com/news/analyst-ratings/guardant-health-stock-rating-reiterated-at-buy-by-td-cowen-on-unitedhealth-coverage-93CH-4773704", "source_name": "Investing.com", "published_at": "2026-07-02T17:12:25", "published_display": "02 Jul 2026 17:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant\u2019s Shield colon cancer blood test snags UnitedHealth coverage", "summary": "Guardant Health's Shield test for colorectal cancer has secured coverage from UnitedHealth, marking the first time a major private U.S. health insurer will reimburse for the screening. This decision expands access to approximately 100 million Americans and is considered a \"waters", "url": "https://www.medtechdive.com/news/guardants-shield-colon-cancer-blood-test-snags-unitedhealth-coverage/824365/", "source_name": "MedTech Dive", "published_at": "2026-07-02T16:12:25", "published_display": "02 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein raises Guardant Health stock price target on UnitedHealth coverage", "summary": "Bernstein SocGen Group increased its price target for Guardant Health (NASDAQ:GH) shares to $200 from $175, maintaining an Outperform rating. This follows UnitedHealth Group's decision to cover Guardant Health's Shield colorectal cancer screening test, a move expected to signific", "url": "https://www.investing.com/news/analyst-ratings/bernstein-raises-guardant-health-stock-price-target-on-unitedhealth-coverage-93CH-4773670", "source_name": "Investing.com", "published_at": "2026-07-02T16:12:25", "published_display": "02 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Guardant Health (GH) Is Up 12.6% After Joining the Russell 1000 and Major Indexes \u2013 And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPbWh5Mjk0S0duVUFBTjlEZmRhLXZvT3VCTWlRbkhaQ2VScFFPbV94em10X2YxeDA0cklZTWdRRkdBVHlUODJiNVBRZ0JzT0R4VFBiTm93Rm0wMjl6NUtPSkNSVTktaE1sc3JHT0tQSGZTY3U2UFhiekl5WDlQMVdONmNKTEhfblFnS2ZPYzNPQm9DWTk2?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) files to resell 4,000 shares via cashless option exercise", "summary": "Guardant Health (GH) has filed a Form 144 to resell 4,000 shares of common stock through a cashless employee option exercise on July 1, 2026. The filing also details recent open-market sales by Meghan V. Joyce in June 2026, totaling 20,203 shares across multiple transactions. The", "url": "https://www.stocktitan.net/sec-filings/GH/144-guardant-health-inc-sec-filing-8d629dc3509a.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:09", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Stock Climbs As Wall Street Targets Surge", "summary": "Guardant Health (GH) stock surged after the FDA cleared its Guardant360 CDx as a companion test for a new HER2-mutant lung cancer drug, boosting investor optimism. Major Wall Street banks, including RBC Capital and Evercore ISI, initiated or upgraded coverage with significantly h", "url": "https://stockstotrade.com/news/guardant-health-inc-gh-news-2026_07_01-2/", "source_name": "StocksToTrade", "published_at": "2026-07-01T19:40:09", "published_display": "01 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Group Now Covers Guardant Health\u2019s Shield Blood Test for Colorectal Cancer Screening", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbC1qWnRta2J3eTFSZGxXSEZEclFSSElSRllpM1lUZ0lyMTB4RnpjRnQ0WGVhajc2UkxtNjNjcDNGTm8wakFlUWFTSHRSNjZJdG9vNWxIbmJ5ZThoMzhuQWNNbFRTYUVUX3Q4TThKUVBXUXZGQkZSemFZQkd3Zk9mWVNSYmJWX2t1dmdLdkZuTEMta2pHcGg3YU1Wck9mNHBudnhrNkRtYWstZFVwQTVRSDB4VjJGbmp4ekRj?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Stock Surges 19%, With A 5-Day Winning Spree", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVjMwa29pZlVNUFZPalNMOXhIZnRtODlvNkZwUERCTXNPN3lNcW85Mk1MVGJobHlKMi1KVDdrelZ4U0lPa3NGb1hmZTB4NWtIT0h5QjNqbU1YNDQ2SzVSMk4xRWlSbnVuVGQ5VDdNUHBCZXFHNXRlZlYwaG91MWJNT0FXc1BCOGl3REtTd1lzaUpSYXVqd1B6TVZqcDdISUV1b0xhRnl1cWVrMlJ2TUs3N2I4MTU2eVZx?oc=5", "source_name": "Trefis", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock After 193% One-Year Gain Is The Rally Running Out Of Room", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are Guardant Health (GH) Shares Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNc3paLVZYaGphUE1yLUlqNHpVOHhOdmZpMDlLTzVObGhRUGdGbTh4b2p6THNwUVptOTBmTXFsV25FNkZLOElfOV9MWjlvSWpvMGdtVExjb29qQjh1b2hBQXZGX2luMTVENlhZVEFZTmVmVVU4TnA2SC1iODhac1lRYzhScUpERkJhdzI5T0xTbnF0bjVDYjN5M1NR?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Could Be 16% Below Fair Value On FDA Approval Win", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Affiliate sells 2,000 shares via cashless exercise \u2014 Guardant Health (NASDAQ: GH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOSHZwcXJsRklXZG9zZjBqS0s2bWo3UFZhcFByeXRMbUc4SVEydlEySUZkaUI1aTAtbnZVejFNTEVUVk9pMDJzaDlfSjlBZ21faUp0YVVERERrVXg0c2VDRU9VaVFIb0FuWVMxOHZqUGFJN0JuNUIxTV9OdGh1R0g1WlVtb3RfQTc1ZHl4dXVDV1JwZHhPV3kzd2tn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock climbs as investors continue to digest screening and diagnostics catalysts | GH Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQS3l3RWVoZzRsZDJlcFhnVmJWUU9DZWxJdlVCdk5NRlpHWkVCX3lWQ3hGT2N5VnFucWkwM3VDbjhJVEoydEx0WlV6MDM5ZjRCMlVHcFNOdVNnaXptWHFRT1ZuclJ3bDhEMkdZQXJlMzdLdXM1OEdDWXIxLWd1MWJYYVRBTTAyZWl0bW9KbXZoUTNVdHZ4Nk96QVZBZWdlbmVNbURUU3VFak5HSm14cEZJbFBEaFJjb0FUbXhhclZUbjJDR25lLW9EUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQZDFPdzA3LVAtYW41VnJnN1c3clh5dUlVVHFqSEEzS2VDWmJtaW52OGlsRGVmb2xoeEZ6QXhLY3Y1QnpYdXBXdVF4ZlhPNDRCY0g0RWNINm1fTFAxNUcwWHg1QUlVeTJ3ZEpUQ2ZMQ2VhTVhLd2ltaGNzeFIxLUp5MFJSeDlUWmlsQVZJWEt2ODJId0Vla3hGd3IySm5uaWs4eU9yb1hVMzV0dnVtR19JSXd4VTA0WVAydnhsSndyMGtOQkduZm1qMmp1SUlEZE8yalpIOW1BTVdMOTNtYVVsM2hVdWJudXFzdV82dmEyNA?oc=5", "source_name": "TradingView", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health insider cashless exercise reported (NASDAQ: GH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQcTI2a3VoNng3ZU5JT3RoeTlQRmFYb1pUVm9INTY0S3ZfdTlGdlFyT3gxX2dzeVk2NDZZal9kX19xc1RNSGFodmxUUFM4em4walR4eWZmYkloYzFsUzhnYko4X3U0aGxmQUVZd09BN2MxWE5jSVQtbF9Vc0ZabmRBc2VDMzkxTWl4bFpRNW0tY2Ric0FNRVRoQ1ln?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock gains on early FDA approval for G360 test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaGRCSHAtOURaU2RyZXByTzE5STVpOXhQTTREUEhVU0lPSDRuQm1WRUMtSml3V0FnMndKZXAzU18wUlloVXVEMldubHROUkJrWVYzMm9RWkpQQ2cyeXVuZFY1Vml1dkNzUjBnRkowSFNDQXgxZUNZOUQzR1h0X2wyRG4wNDNLZzZHQTBTUjJWeTBubHpQOW8zOEtZYmVOZThlZWlIM19VUE1kck1lNGQyb0ZSTzRmUXNLeW5HbmxLT00?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Guardant Health (GH) Stock Is Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQc1Z3Sk5FSE5mcV84QWZhZGR3cEZSNVFOT3Q0TkM0WVUzVnpjY2V3VTUzV2JteDk2VWxZU2xLZGNFeWcxcWktUGZjb3lhT3k5cFJfT2owbGRZQjFGejZMVHdReE9MZGdiSVpZSDNoUl9wOHdMM2daYjNzUS12YXktMDRWNF85RnQ3UHhDWFY0d1Z5ZlJvd3JlRA?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Guardant Health Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPYmxzMnhCb0F0TmI2V3ktb2M5TXFBYnN6c2I0WjVQZEVBS0tnT0tFRERpdy1jVUJPYW01N2Y3ci1QTWNIbjlhaV9oWnBmSzJsVENWaXZvbUwtZklSTFJ0OEpFTGdsYUp4QkZubElJUDJ5NnhUclJpNjJDTGJIZTF5WXdhUW9sWUd4eG5raHNwaVc0MzNkb0NpREttTTJjUlljZHlRWXlQSnVuZnVuTkY0ZWp5aWVfTEJrX3RLSGxuR2xPc1ZlaFRwMUQ5RjZiLTjSAdQBQVVfeXFMTmt2U2t0SFd4d29ZdU5yU0FTTHFHeE5zVm42aHI3SkRIVnR1WkIybFhoZHRFcFFyNC1URDluRzRNOXJlc0ZEVmlhcHltZVp1RVpVZXlzRVpSSlY1eDdmM21XYUxpNUdfWWJ5b2tpZHdZZUJJdXpFNTZ0d1hTNVoteDRIWG83T2kxRVRWa3UzWHRWdGVzb0FWYWg5R256eG9iQUJyRmtpb0F0NVU3VG5oOHliNVI2SFFDZjNCZDByNFppWjUyM1c0TzBzX0Qzb0tSa0txb1c?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-02T07:00:00+00:00", "published_display": "02 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOV2pKSkRDQWlCc3Jpek50UWxIc1VLTGV0bnE5bzdLVVVCRWVBSEw4WnV6QVVRVUhzX2tIQVhHNl9sOG9GT3h3UlBiaDVZbDdfVmpTNjhTMV9JangwZ3ZKZGoyOW9KVFR4QlVBeDVmbUhOdVg4N182cjlLdVRRYzh5YWVYRWF1RGJ4OXlUWFFsSTlpdDFCYVIzT2VUZ0ZUM3ZBMTdVemFxTFF5dw?oc=5", "source_name": "StockStory", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How Expanded Coverage for Guardant\u2019s Shield Test Will Impact UnitedHealth Group (UNH) Investors", "summary": "UnitedHealth Group's decision to cover Guardant Health's Shield blood test for colorectal cancer screening for roughly 40 million members over 45 aligns with its focus on preventive care. While this move supports UnitedHealth's long-term investment narrative through innovation an", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-expanded-coverage-for-guardants-shield-test-will-impact/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T05:11:51", "published_display": "15 Jul 2026 05:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GH Maintained by Canaccord Genuity -- Price Target Raised to $20", "summary": "Canaccord Genuity has maintained a \"Buy\" rating for Guardant Health (GH) and raised its price target from $135 to $205, reflecting strong confidence in the company's future performance. Despite this positive analyst outlook and significant growth potential, Guardant Health's stoc", "url": "https://www.gurufocus.com/news/8957532/gh-maintained-by-canaccord-genuity-price-target-raised-to-205", "source_name": "GuruFocus", "published_at": "2026-07-14T14:16:23", "published_display": "14 Jul 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Expands Shield Test Access in India, But What Does It Reveal About Its Growth Strategy?", "summary": "Guardant Health (GH) is expanding access to its Shield Multi-Cancer Detection blood test in India through an agreement with Zydus Lifesciences and Apollo Hospitals. This move into a large healthcare market aims to broaden non-invasive cancer screening access and is part of Guarda", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-expands-shield-test-access-in-india-but-w/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-14T11:11:16", "published_display": "14 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Receives a Buy from Bank of America Securities", "summary": "Bank of America Securities reiterated a Buy rating for Guardant Health (GH) with a price target of $190.00. This recommendation comes despite a negative corporate insider sentiment, with more insiders selling shares recently. Guardant Health reported a quarterly revenue of $301.6", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3268965/guardant-health-gh-receives-a-buy-from-bank-of-america-securities/", "source_name": "The Globe and Mail", "published_at": "2026-07-14T10:11:16", "published_display": "14 Jul 2026 10:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scrap metal to hydrogen: GH Power\u2019s tech heads for NYSE via Matinas deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQWEZwZVplTHo4SE05TkVYQ0NWLTZEV2dBSkZyYlBwanFJZ1B0dnZZaDY2OEF6Mi1zRFZEakdfTWZDYkpZbHE5R1N0VzJtNVF4ZUJ5WGNFWGFKd0RNTkxuRDNxM3lKeEF3OGZTVXVONDZSMDFOcEVWeTJJWkQ0Q0pEXzVudDFaMWRVdGlzazNKNUxEbWd1eGR0S0lsSjE4QU9GbGJzMl9qTXIteUFHTFVMekJ5dldRZEhMR056ZXItaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T19:45:00+00:00", "published_display": "13 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Expanded Coverage of Guardant\u2019s Shield Test Reshape UnitedHealth Group\u2019s (UNH) Preventive Care Narrative?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/expanded-coverage-guardant-shield-test-100645520.html", "source_name": "Simply Wall St.", "published_at": "2026-07-13T10:06:45+00:00", "published_display": "13 Jul 2026 10:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Expands Shield In India On Valuation Views Staying Closely Split", "summary": "Guardant Health (GH) recently announced partnerships with Zydus Lifesciences and Apollo Hospitals to launch its Shield Multi Cancer Detection blood test in India. The stock has seen significant momentum, but valuation views are split, with some analysts considering it slightly ov", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-expands-shield-in-india-on-valuation-view", "source_name": "Simply Wall Street", "published_at": "2026-07-12T19:40:27", "published_display": "12 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $175", "summary": "Morgan Stanley has reiterated its \"Buy\" rating on Guardant Health (GH.US) and increased its price target to $175. This positive outlook suggests continued confidence from the financial institution in the company's growth prospects. The raised target price indicates a belief in po", "url": "https://www.moomoo.com/news/post/72713728/morgan-stanley-maintains-guardant-health-ghus-with-buy-rating-raises", "source_name": "Moomoo", "published_at": "2026-07-10T05:10:57", "published_display": "10 Jul 2026 05:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High", "summary": "", "url": "https://finance.yahoo.com/m/de3508cb-1479-32d9-aa1c-a2f6bccc4228/the-surprising-reason.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-09T20:23:19+00:00", "published_display": "09 Jul 2026 20:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/guardant-health-report-second-quarter-200500522.html", "source_name": "Business Wire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026", "summary": "Guardant Health (NASDAQ: GH) will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will also host a conference call and webcast to discuss the results and provide a business update at 4:30 PM ET / 1:30 PM PT on the same ", "url": "https://www.moomoo.com/news/post/72736063/press-release-guardant-health-to-report-second-quarter-2026-financial", "source_name": "Moomoo", "published_at": "2026-07-09T20:51:31", "published_display": "09 Jul 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock May Be Fully Priced As Shield Coverage Expands", "summary": "Guardant Health (GH) has seen a strong 3-year return of 313.6%. While a Discounted Cash Flow (DCF) model suggests the stock is undervalued by 16.1% at around $186 per share, market-based multiples, particularly the P/S ratio of 19.2x (compared to an industry average of 1.5x), ind", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-may-be-fully-priced-as-shield-cover", "source_name": "Simply Wall Street", "published_at": "2026-07-09T19:51:31", "published_display": "09 Jul 2026 19:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health sets July 30 call for Q2 2026 results", "summary": "Guardant Health (Nasdaq: GH) announced it will report its second-quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The webcast will ", "url": "https://www.stocktitan.net/news/GH/guardant-health-to-report-second-quarter-2026-financial-results-on-j1qbfbjdgjp8.html", "source_name": "Stock Titan", "published_at": "2026-07-09T17:11:16", "published_display": "09 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. Stock 12\u2011Month Price Target Raised to $161.13, Implies 3% Upside", "summary": "Guardant Health, Inc. (GH) has seen its average 12-month price target raised to $161.13 by 23 analysts, up from $159.17, implying a 3% potential upside from its July 8 closing price. The consensus rating for GH remains a \"Buy\" among 29 analysts, with 25 recommending Buy, 2 Hold, ", "url": "https://www.tradingview.com/news/tradingview:ffee8f602e118:0-guardant-health-inc-stock-12-month-price-target-raised-to-161-13-implies-3-upside/", "source_name": "TradingView", "published_at": "2026-07-09T13:41:18", "published_display": "09 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Slides as Investors Appear to Take Profits After Recent Rally", "summary": "This article analyzes Guardant Health's stock performance, noting a recent decline likely due to profit-taking after a rally. It will detail the company's financial health, analyst forecasts, and various metrics to provide context for investors. The report aims to offer a compreh", "url": "https://www.moomoo.com/news/post/72694841/guardant-health-slides-as-investors-appear-to-take-profits-after", "source_name": "Moomoo", "published_at": "2026-07-08T21:41:18", "published_display": "08 Jul 2026 21:41", "sentiment": "negative", "sentiment_pct": 32, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Guardant Health, Inc. Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold Guardant Health, Inc. stocks, providing key financial metrics for each. The data includes market value, weight, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year NAV total re", "url": "https://www.tradingview.com/symbols/MIL-1GH/etfs/", "source_name": "TradingView", "published_at": "2026-07-07T12:12:28", "published_display": "07 Jul 2026 12:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To UnitedHealth Group (UNH) Covering Guardant\u2019s Shield Blood Test For Colon Cancer", "summary": "UnitedHealth Group has announced coverage for Guardant Health's Shield blood test for colorectal cancer screening for eligible members, making it the first major commercial insurer to do so. While this move strengthens UnitedHealth's preventive care focus, the article suggests it", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-investors-may-respond-to-unitedhealth-group-unh-covering/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-07T07:12:28", "published_display": "07 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. Stock 12\u2011Month Price Target Raised to $156.35, Implies 7% Downside", "summary": "Analyst estimates for Guardant Health, Inc. (GH) show an average 12-month price target increase from $153.96 to $156.35, implying a potential 7% downside from the current closing price. Despite this, the consensus rating from 29 analysts remains \"Buy,\" with a majority recommendin", "url": "https://www.tradingview.com/news/tradingview:2c5a4dcdae377:0-guardant-health-inc-stock-12-month-price-target-raised-to-156-35-implies-7-downside/", "source_name": "TradingView", "published_at": "2026-07-06T16:40:40", "published_display": "06 Jul 2026 16:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock hits 52-week high at $172.67", "summary": "Guardant Health Inc. (GH) stock recently hit a 52-week high of $172.67, with a year-over-year total return of 232.63%. Despite its robust performance and 39.56% revenue growth, InvestingPro analysis suggests the stock is overvalued and potentially overbought. The company also rec", "url": "https://www.investing.com/news/company-news/guardant-health-stock-hits-52week-high-at-17267-93CH-4777030", "source_name": "Investing.com", "published_at": "2026-07-06T15:40:40", "published_display": "06 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA Securities Adjusts Price Target on Guardant Health to $190 From $135", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bofa-securities-adjusts-price-target-123817219.html", "source_name": "MT Newswires", "published_at": "2026-07-06T12:38:17+00:00", "published_display": "06 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health: Great Execution, But At An Excessive Premium (NASDAQ:GH)", "summary": "Guardant Health (GH) is seeing increased credibility for its Shield product, supported by Quest access and expanded coverage, alongside a strong oncology franchise. While the company's execution is strong and the stock has risen sharply, the author believes the current valuation ", "url": "https://seekingalpha.com/article/4920051-guardant-health-great-execution-but-at-an-excessive-premium?source=generic_rss", "source_name": "Seeking Alpha", "published_at": "2026-07-06T10:15:00", "published_display": "06 Jul 2026 10:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion", "summary": "Guardant Health (GH) recently saw a 12.6% stock increase following two significant developments: an exclusive deal with Zydus Lifesciences to bring its Shield Multi-Cancer Detection blood test to India, and expanded coverage for the Shield test through UnitedHealth. These agreeme", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-is-up-126-after-india-shield-cancer-test", "source_name": "Simply Wall Street", "published_at": "2026-07-06T03:10:37", "published_display": "06 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock surges on colon cancer blood test news", "summary": "Guardant Health's stock surged after UnitedHealth Group agreed to cover its Shield blood test for colon cancer as a first-line screening option for millions of members. This decision led Bernstein SocGen Group to raise its price target for Guardant Health to $200, highlighting a ", "url": "https://www.thestreet.com/investing/stocks/gh-guardant-health-stock-target-bernstein-colon-cancer-blood-test", "source_name": "TheStreet", "published_at": "2026-07-05T15:39:38", "published_display": "05 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CPO logs RSU vesting and $170.77 tax-withholding share transfer", "summary": "Guardant Health's Chief People Officer, Terilyn J. Monroe, reported the vesting of 4,020 restricted stock units (RSUs) on July 1, 2026. The company withheld 2,099 shares at $170.77 per share to cover tax obligations. Following these transactions, Ms. Monroe retains a significant ", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-c1f285b2c34d.html", "source_name": "Stock Titan", "published_at": "2026-07-03T13:40:29", "published_display": "03 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock May Look Fully Valued Following Shield Coverage News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTzNxVHdpMjQzWGtvSmhuODBUVlNOS0tvdG9PQl8wejFPM0txM0d5Z21rajEwUThrWkd1dzFoWGlKaVdBNC1ldGNQZlIyUVptUFljQnA1SUpRQy1hcW02cGw1T2YzcWtHdUJCX2dZVy1Nb2dfSFpLNTVwWHY5Z1lyWEg3eHRNZm5fLUZiVTZ1RDMxX2pFdVpveg?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CLO exercises RSUs as shares withheld for taxes", "summary": "Guardant Health's Chief Legal Officer, John G. Saia, had 7,063 restricted stock units (RSUs) vest, converting into common stock on July 1, 2026. The company withheld 3,707 shares, valued at $170.77 per share, to cover tax obligations related to this vesting event. This transactio", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-8c9f4050172b.html", "source_name": "Stock Titan", "published_at": "2026-07-03T02:09:26", "published_display": "03 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) director converts 155 RSUs into common shares", "summary": "Guardant Health director Steve E. Krognes converted 155 Restricted Stock Units (RSUs) into common shares on June 30, 2026. This transaction represents a compensation-related vesting event and not an open-market purchase or sale. After the conversion, Mr. Krognes directly holds 14", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-93e5ebf47f2e.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:12:25", "published_display": "02 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) CCO receives 7,414 shares from RSU vesting and tax withholding", "summary": "Guardant Health's Chief Commercial Officer, Chris Freeman, received 7,414 shares through the vesting of restricted stock units (RSUs) on July 1, 2026. This transaction involved the conversion of RSU awards into common stock, with 3,141 shares withheld by the company to cover tax ", "url": "https://www.stocktitan.net/sec-filings/GH/form-4-guardant-health-inc-insider-trading-activity-ee7cb37ac0fb.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:12:25", "published_display": "02 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock rating reiterated at Buy by TD Cowen on UnitedHealth coverage", "summary": "TD Cowen has reiterated a Buy rating and a $127.00 price target for Guardant Health (NASDAQ:GH) following UnitedHealth's decision to cover the Shield colorectal cancer screening test. This coverage, effective August 1, 2026, for average-risk individuals aged 45-85, is expected to", "url": "https://www.investing.com/news/analyst-ratings/guardant-health-stock-rating-reiterated-at-buy-by-td-cowen-on-unitedhealth-coverage-93CH-4773704", "source_name": "Investing.com", "published_at": "2026-07-02T17:12:25", "published_display": "02 Jul 2026 17:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant\u2019s Shield colon cancer blood test snags UnitedHealth coverage", "summary": "Guardant Health's Shield test for colorectal cancer has secured coverage from UnitedHealth, marking the first time a major private U.S. health insurer will reimburse for the screening. This decision expands access to approximately 100 million Americans and is considered a \"waters", "url": "https://www.medtechdive.com/news/guardants-shield-colon-cancer-blood-test-snags-unitedhealth-coverage/824365/", "source_name": "MedTech Dive", "published_at": "2026-07-02T16:12:25", "published_display": "02 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein raises Guardant Health stock price target on UnitedHealth coverage", "summary": "Bernstein SocGen Group increased its price target for Guardant Health (NASDAQ:GH) shares to $200 from $175, maintaining an Outperform rating. This follows UnitedHealth Group's decision to cover Guardant Health's Shield colorectal cancer screening test, a move expected to signific", "url": "https://www.investing.com/news/analyst-ratings/bernstein-raises-guardant-health-stock-price-target-on-unitedhealth-coverage-93CH-4773670", "source_name": "Investing.com", "published_at": "2026-07-02T16:12:25", "published_display": "02 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Guardant Health (GH) Is Up 12.6% After Joining the Russell 1000 and Major Indexes \u2013 And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPbWh5Mjk0S0duVUFBTjlEZmRhLXZvT3VCTWlRbkhaQ2VScFFPbV94em10X2YxeDA0cklZTWdRRkdBVHlUODJiNVBRZ0JzT0R4VFBiTm93Rm0wMjl6NUtPSkNSVTktaE1sc3JHT0tQSGZTY3U2UFhiekl5WDlQMVdONmNKTEhfblFnS2ZPYzNPQm9DWTk2?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) files to resell 4,000 shares via cashless option exercise", "summary": "Guardant Health (GH) has filed a Form 144 to resell 4,000 shares of common stock through a cashless employee option exercise on July 1, 2026. The filing also details recent open-market sales by Meghan V. Joyce in June 2026, totaling 20,203 shares across multiple transactions. The", "url": "https://www.stocktitan.net/sec-filings/GH/144-guardant-health-inc-sec-filing-8d629dc3509a.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:09", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Stock Climbs As Wall Street Targets Surge", "summary": "Guardant Health (GH) stock surged after the FDA cleared its Guardant360 CDx as a companion test for a new HER2-mutant lung cancer drug, boosting investor optimism. Major Wall Street banks, including RBC Capital and Evercore ISI, initiated or upgraded coverage with significantly h", "url": "https://stockstotrade.com/news/guardant-health-inc-gh-news-2026_07_01-2/", "source_name": "StocksToTrade", "published_at": "2026-07-01T19:40:09", "published_display": "01 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Group Now Covers Guardant Health\u2019s Shield Blood Test for Colorectal Cancer Screening", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbC1qWnRta2J3eTFSZGxXSEZEclFSSElSRllpM1lUZ0lyMTB4RnpjRnQ0WGVhajc2UkxtNjNjcDNGTm8wakFlUWFTSHRSNjZJdG9vNWxIbmJ5ZThoMzhuQWNNbFRTYUVUX3Q4TThKUVBXUXZGQkZSemFZQkd3Zk9mWVNSYmJWX2t1dmdLdkZuTEMta2pHcGg3YU1Wck9mNHBudnhrNkRtYWstZFVwQTVRSDB4VjJGbmp4ekRj?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health Stock Surges 19%, With A 5-Day Winning Spree", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVjMwa29pZlVNUFZPalNMOXhIZnRtODlvNkZwUERCTXNPN3lNcW85Mk1MVGJobHlKMi1KVDdrelZ4U0lPa3NGb1hmZTB4NWtIT0h5QjNqbU1YNDQ2SzVSMk4xRWlSbnVuVGQ5VDdNUHBCZXFHNXRlZlYwaG91MWJNT0FXc1BCOGl3REtTd1lzaUpSYXVqd1B6TVZqcDdISUV1b0xhRnl1cWVrMlJ2TUs3N2I4MTU2eVZx?oc=5", "source_name": "Trefis", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock After 193% One-Year Gain Is The Rally Running Out Of Room", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are Guardant Health (GH) Shares Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNc3paLVZYaGphUE1yLUlqNHpVOHhOdmZpMDlLTzVObGhRUGdGbTh4b2p6THNwUVptOTBmTXFsV25FNkZLOElfOV9MWjlvSWpvMGdtVExjb29qQjh1b2hBQXZGX2luMTVENlhZVEFZTmVmVVU4TnA2SC1iODhac1lRYzhScUpERkJhdzI5T0xTbnF0bjVDYjN5M1NR?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Could Be 16% Below Fair Value On FDA Approval Win", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQWkRWQ2c2TWhYSzVIbUlGekU2a1kzSFFfRW1GdUV5NEQ4Z2JQZUhTR0tnVTEzQnpuLVB4TU9ubWpXXzNnd0lBdDdSY0gySV9jMzM2QlRZNXdoeC02aV9LcTUtaWxyaTdYTWdVc1B1TXgwYXVxb1c3QmxONjBkRGNZSWstNm9UbW1fVWlPZm15dGYzYzE4UHhsTjVvTmhoMDRaZUZsSDFRZmc4aGozTmFoVjJqUkVXR2hiTUtNdk41c1NjemQ5QUkxdU84VzdmelHSAdQBQVVfeXFMTU56bVVjOU9HWGtpMnlKVGViR1UzUDkwNkN4dXhiRkVnaEdZMGotc3QzVzVHbzA1TkNjeERiazAzX2ZFZmJvY3VtSm4xMWtEWXBDQUpRVEc1blpabVpnWG1BZEJPQ2x1Y2ZUTzhFdVZabVhlT0F2UjRSSnBDYnNtUmN6czJlWDh4N1drVjUyRVFZaHc1VDRGMjNFMmE5ZHc4YjZuZFc1cTdfT0dHYjZnRW1wRHV2QkR5UzV0WF9ZbUl6TmlnTm44emV1amM5b052eW1GZS0?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Affiliate sells 2,000 shares via cashless exercise \u2014 Guardant Health (NASDAQ: GH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOSHZwcXJsRklXZG9zZjBqS0s2bWo3UFZhcFByeXRMbUc4SVEydlEySUZkaUI1aTAtbnZVejFNTEVUVk9pMDJzaDlfSjlBZ21faUp0YVVERERrVXg0c2VDRU9VaVFIb0FuWVMxOHZqUGFJN0JuNUIxTV9OdGh1R0g1WlVtb3RfQTc1ZHl4dXVDV1JwZHhPV3kzd2tn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock climbs as investors continue to digest screening and diagnostics catalysts | GH Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQS3l3RWVoZzRsZDJlcFhnVmJWUU9DZWxJdlVCdk5NRlpHWkVCX3lWQ3hGT2N5VnFucWkwM3VDbjhJVEoydEx0WlV6MDM5ZjRCMlVHcFNOdVNnaXptWHFRT1ZuclJ3bDhEMkdZQXJlMzdLdXM1OEdDWXIxLWd1MWJYYVRBTTAyZWl0bW9KbXZoUTNVdHZ4Nk96QVZBZWdlbmVNbURUU3VFak5HSm14cEZJbFBEaFJjb0FUbXhhclZUbjJDR25lLW9EUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQZDFPdzA3LVAtYW41VnJnN1c3clh5dUlVVHFqSEEzS2VDWmJtaW52OGlsRGVmb2xoeEZ6QXhLY3Y1QnpYdXBXdVF4ZlhPNDRCY0g0RWNINm1fTFAxNUcwWHg1QUlVeTJ3ZEpUQ2ZMQ2VhTVhLd2ltaGNzeFIxLUp5MFJSeDlUWmlsQVZJWEt2ODJId0Vla3hGd3IySm5uaWs4eU9yb1hVMzV0dnVtR19JSXd4VTA0WVAydnhsSndyMGtOQkduZm1qMmp1SUlEZE8yalpIOW1BTVdMOTNtYVVsM2hVdWJudXFzdV82dmEyNA?oc=5", "source_name": "TradingView", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health insider cashless exercise reported (NASDAQ: GH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQcTI2a3VoNng3ZU5JT3RoeTlQRmFYb1pUVm9INTY0S3ZfdTlGdlFyT3gxX2dzeVk2NDZZal9kX19xc1RNSGFodmxUUFM4em4walR4eWZmYkloYzFsUzhnYko4X3U0aGxmQUVZd09BN2MxWE5jSVQtbF9Vc0ZabmRBc2VDMzkxTWl4bFpRNW0tY2Ric0FNRVRoQ1ln?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health stock gains on early FDA approval for G360 test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaGRCSHAtOURaU2RyZXByTzE5STVpOXhQTTREUEhVU0lPSDRuQm1WRUMtSml3V0FnMndKZXAzU18wUlloVXVEMldubHROUkJrWVYzMm9RWkpQQ2cyeXVuZFY1Vml1dkNzUjBnRkowSFNDQXgxZUNZOUQzR1h0X2wyRG4wNDNLZzZHQTBTUjJWeTBubHpQOW8zOEtZYmVOZThlZWlIM19VUE1kck1lNGQyb0ZSTzRmUXNLeW5HbmxLT00?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Guardant Health (GH) Stock Is Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQc1Z3Sk5FSE5mcV84QWZhZGR3cEZSNVFOT3Q0TkM0WVUzVnpjY2V3VTUzV2JteDk2VWxZU2xLZGNFeWcxcWktUGZjb3lhT3k5cFJfT2owbGRZQjFGejZMVHdReE9MZGdiSVpZSDNoUl9wOHdMM2daYjNzUS12YXktMDRWNF85RnQ3UHhDWFY0d1Z5ZlJvd3JlRA?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Guardant Health Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-02T07:00:00+00:00", "published_display": "02 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guardant Health (GH) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOV2pKSkRDQWlCc3Jpek50UWxIc1VLTGV0bnE5bzdLVVVCRWVBSEw4WnV6QVVRVUhzX2tIQVhHNl9sOG9GT3h3UlBiaDVZbDdfVmpTNjhTMV9JangwZ3ZKZGoyOW9KVFR4QlVBeDVmbUhOdVg4N182cjlLdVRRYzh5YWVYRWF1RGJ4OXlUWFFsSTlpdDFCYVIzT2VUZ0ZUM3ZBMTdVemFxTFF5dw?oc=5", "source_name": "StockStory", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 103, "total_relevant": 53, "sentiment_summary": {"positive": 16, "negative": 3, "neutral": 34, "score": 55, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 16.3, "count": 29}, {"event": "analyst", "label": "Analyst action", "weight": 5.5, "count": 10}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 8}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 16, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 160.05, "latest_week": "2026-07-10", "one_week_move": -4.7, "four_week_move": 21.6, "twelve_week_move": 77.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.294252, "market_dynamics_buy_signal": false, "relative_strength": 50.275486, "fair_value_gap": 208.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.6683, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.7% over one week, +21.6% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "Simply Wall Street", "count": 6}, {"label": "Market source", "count": 6}, {"label": "simplywall.st", "count": 6}, {"label": "TradingView", "count": 4}, {"label": "Investing.com", "count": 4}, {"label": "Moomoo", "count": 3}, {"label": "GuruFocus", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 53}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Analyst action", "count": 10}, {"label": "Earnings", "count": 8}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "53", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.7% over one week, +21.6% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "How Expanded Coverage for Guardant\u2019s Shield Test Will Impact UnitedHealth Group (UNH) Investors"}], "updated_at": "2026-07-16T06:05:03.773287+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}